Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jose L. Chavelas-Reyes has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bovine Tuberculosis as a Neglected Zoonotic Disease in Mexico and Latin America: Epidemiological Challenges, Diagnostic Insights, and Public Health Implications in Emerging Economies

    by Luis M. Rodríguez-Martínez, Jose L. Chavelas-Reyes, Carlo F. Medina-Ramírez, Jorge A. Valdés-González, Eli Fuentes-Chávez, Carlos A. Ríos-Saldaña, Miguel A. de León-Zapata, Josefina G. Rodríguez-González

    Bovine tuberculosis (bTB), caused by Mycobacterium bovis, remains one of the most relevant zoonotic diseases worldwide due to its dual impact on livestock production and human health. Although zoonotic tuberculosis has been virtually eradicated from cattle in a few settings, particularly in Australia, the disease persists in much of Latin America, Africa, and Asia, where it continues to limit cattle productivity and pose a threat to public health through the consumption of unpasteurized dairy products and occupational exposure. This review integrates historical, epidemiological, clinical, and molecular perspectives of bTB, with particular emphasis on Mexico, highlighting the role of wildlife reservoirs, socioeconomic factors, and diagnostic limitations in maintaining endemicity. Recent advances in molecular epidemiology, such as PCR, MIRU-VNTR, and whole-genome sequencing, provide promising avenues for surveillance and control. Finally, we discuss the importance of adopting a One Health framework that bridges veterinary, medical, and environmental approaches to achieve sustainable control of this silent zoonosis.


  • Open Access

    Molecular Epidemiology of Mycobacterium tuberculosis in Mexico

    by Luis M. Rodríguez-Martínez, Jose L. Chavelas-Reyes, Carlo F. Medina-Ramírez, Eli Fuentes-Chávez, Zurisaday S. Muñoz-Troncoso, Ángeles G. Estrada-Vega, Enrique Rodríguez-Díaz, Diego Torres-Morales, María G. Moreno-Treviño, Josefina G. Rodríguez-González

    Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.


  • Open Access

    Gender, Immunological Response, and COVID-19: An Assessment of Vaccine Strategies in a Pandemic Region of Oaxaca, México

    by Luis M. Rodríguez-Martínez, José L. Chavelas-Reyes, Carlo F. Medina-Ramírez, Francisco J. Cabrera-Santos, Nadia A. Fernández-Santos, Jesús A. Aguilar-Durán, Sonia M. Pérez-Tapia, Josefina G. Rodríguez-González, Mario A. Rodríguez Pérez

    COVID-19 is no longer a public health emergency of international concern, but long COVID’s effects are yet to be fully understood. Hence, globally, SARS-CoV-2 is still a profound threat to public health and of perilous nature as a zoonotic disease. Timely vaccination provided to individuals worldwide during the pandemic phase was under a certain degree of control; however, few studies have reported the effectiveness of vaccines administered in Mexico, and its surveillance is paramount. Furthermore, an unknown proportion of Mexican individuals have not yet received any vaccine, and the circulation of the Omicron, Pirola, and FLiRT variants is ongoing. A cross-sectional serology survey study design was employed, involving 150 individuals from Southern Mexico (Oaxaca) whose humoral immune responses after vaccination were tested by an ELISA; the receptor-binding domain of the SARS-CoV-2 spike protein served as a recombinant antigen in the ELISA. One hundred thirty-nine out of 150 individuals (92.6%; 95%-CI = 87–95%) examined were positive for the ELISA, but in 11 individuals, the vaccines did not induce any immune response. Interestingly, the immune responses (antibody prevalence and levels) of females (58%) were higher (T= −2.21; p-value = 0.02) than those of males (41%). However, in this sample population of Southern Mexico, age, vaccine type, comorbidity, and body mass index did not have any effect (p > 0.05) after COVID-19 vaccination. Taking all results together, here, we present factors that affected immune responses of individuals during the first vaccination campaign in Oaxaca, Mexico; however, vaccine surveillance during the post-pandemic phase needs further investigation.